# Naluri Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/naluri-pte

- Industry: Healthcare IT
- Headquarters: Singapore, Singapore
- Website: www.naluri.life/
- Total disclosed funding: $21M
- Latest round: Series B (Aug 12, 2025)
- Investors on record: 19

## About

Based in Singapore, Naluri Pte. Ltd. operates a workplace wellness platform that focuses on enhancing employees' mental, physical, and emotional health through innovative programs and AI-driven support.Naluri Pte. Ltd. was founded in 2017 and is headquartered in Singapore. The company specializes in employee wellness solutions. Jeremy Ting, the founder, has a history of developing health-focused initiatives. To date, Naluri has completed 7 deals, with its most recent funding being a Series B round on August 12, 2025, where the company raised USD 5.00 mn led by TELUS Pollinator Fund for Good alongside M Venture Partners and Sumitomo Corporation Equity Asia. The total amount raised amounts to USD 5.00 mn, as this round represents the entire funding raised thus far.Naluri offers a comprehensive suite of workplace and employee wellness programs designed to enhance the mental, physical, emotional, and financial health of employees. Their core services include an Employee Assistance Programme, performance coaching and training, consultations, and chronic disease management programs tailored for conditions such as mental health issues, obesity, diabetes, hypertension, and cholesterol management. The company employs an innovative AI Care Companion named Luna, which provides personalized insights and actionable steps based on an assessment of users' mental, work, and social health. Naluri primarily serves employers, insurers, and individuals across diverse geographical markets, including Southeast Asia and potentially expanding into other regions, focusing on integrating health solutions that are backed by clinical research and medical expertise.Naluri's revenue model is structured around B2B partnerships and direct-to-consumer offerings, where clients engage in subscription-based services for continued access to their wellness programs. Organizations may enter into contracts to provide Naluri's services to their employees, which typically includes a fixed fee structure for the assessment and ongoing support services. The company’s flagship offerings, such as the Employee Assistance Programme and chronic disease management services, are designed to provide scalable solutions across various employee demographics. The financial framework for these services often includes tiered pricing based on the number of employees enrolled and the specific services selected, ensuring that organizations receive tailored solutions aimed at improving employee wellness and productivity.In August 2025, Naluri Pte. Ltd. raised USD 5 million in Series B funding, part of a larger USD 14 million round, to accelerate its expansion into Southeast Asia, particularly targeting the Philippines and Vietnam. The company plans to utilize the recent funding to enhance its product offerings and explore new market opportunities in these regions.

## Funding rounds

- Series B, Aug 12, 2025, $5M — Sumitomo Corporation Equity Asia, M Venture Partners, TELUS Pollinator Fund for Good
- Series B, Jun 21, 2022, $7M — Bertelsmann Capital Ventures, Pruksa Real Estate, Palm Drive Capital, INP Capital, Striders, M Venture Partners
- Series A, Jun 6, 2021, $7.7M — KB Investment, 500 Global, Rocket Internet SE, Global Founders Capital, Sumitomo Corporation Equity Asia, Stanford-StartX Fund, Palm Drive Capital, Integra Partners, RHL Ventures, BioMark, TH Capital, Duopharma Biotech Berhad, INP Capital, M Venture Partners, ACE PURSUIT SDN. BHD.
- Seed, Jul 24, 2019, $1.5M — Global Founders Capital, Stanford-StartX Fund, TH Capital
- Seed, Jan 29, 2018, $0.3M — 500 Global, BioMark

## Investors

- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed, Series A
- BioMark — Seed, Series A
- Global Founders Capital (https://capitalatlas.ai/funds/global-founders-capital) — Seed, Series A
- Stanford-StartX Fund — Seed, Series A
- TH Capital (https://capitalatlas.ai/funds/th-capital) — Seed, Series A
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A
- Rocket Internet SE (https://capitalatlas.ai/funds/rocket-internet-se) — Series A
- Sumitomo Corporation Equity Asia (https://capitalatlas.ai/funds/sumitomo-corporation-equity-asia) — Series A, Series B
- Palm Drive Capital (https://capitalatlas.ai/funds/palm-drive-capital) — Series A, Series B
- Integra Partners (https://capitalatlas.ai/funds/integra-partners) — Series A
- RHL Ventures (https://capitalatlas.ai/funds/rhl-ventures) — Series A
- Duopharma Biotech Berhad — Series A
- INP Capital (https://capitalatlas.ai/funds/inp-capital) — Series A, Series B
- M Venture Partners (https://capitalatlas.ai/funds/m-venture-partners) — Series A, Series B
- ACE PURSUIT SDN. BHD. — Series A
- Bertelsmann Capital Ventures — Series B
- Pruksa Real Estate — Series B
- Striders — Series B
- TELUS Pollinator Fund for Good (https://capitalatlas.ai/funds/telus-pollinator-fund-for-good) — Series B